HOME > > Products > PRONULIFE® (Probiotic) > PRONULIFE® FitStay

PRONULIFE® FitStay

Share to
Global Health Challenge: Obesity as a Chronic Disease That Cannot Be Ignored
The World Health Organization (WHO) and the Europeanhave classified obesity as a chronic disease. The global obese population is projected to reach 1.9 billion by 2035, underscoring its severe health impact. Traditional approaches to weight loss, such as dieting or medications, are often accompanied by side effects and risks of weight regain.
Research indicates that probiotics may help regulate gut microbiota, support gut–brain axis health, and participate in fat metabolism-related processes, offering new directions for healthy weight management.


PRONULIFE® FitStay – A Science-Backed Probiotic for Weight Management

Clinical studies on the PRONULIFE® FitStay formulation have shown that it:
  • May help support healthy weight management
  • Has been shown in research to help maintain normal blood lipid levels
  • Supports normal metabolic functions and serves as a nutritional supplement within a balanced diet
Studies suggest that related strains may act through the following mechanisms:
  • Participating in bile salt–related metabolic processes
  • Influencing the lipid metabolism environment in the intestines
  • Supporting gut microbiota balance
Clinical research in both adults and children has shown varying degrees of body weight change during the study period. Gut microarray analysis confirmed that beneficial bacteria associated with healthy metabolism (such as Bifidobacterium animalis and Lactobacillus salivarius) increased in abundance, helping optimize gut microbiota.

Patented Multi-Strain Formulation

PRONULIFE® FitStay adopts an exclusive multi-strain combination, combined with Glac’s PRONEX® micro-encapsulation technology, to ensure probiotic stability and high quality throughout its shelf life.
Functional Probiotic IngredientStrain Combination
PRONULIFE® FitStayBifidobacterium animalis subsp. lactis CP-9
Lactobacillus rhamnosus bv-77
 

Patent Support

  • TW I572713, CN ZL201510074689.7, TW I782550, and US 17/449699 – multiple patents related to anti-obesity probiotic applications


PRONULIFE® FitStay integrates patented technologies with clinical validation, offering safe, science-based, and competitive probiotic solutions for weight management to brand owners and ODM/OEM partners.

📧 Contact us: glac@glac.com.tw
 
Further Reading: PRONULIFE® Functional Probiotic Ingredients🔙
 


References

  1. European Commission
  2. A diet high in sugar and fat influences neurotransmitter metabolism and then affects brain function by altering the gut microbiota
  3. A Combined Supplement of Probiotic Strains AP-32, bv-77, and CP-9 Increased Akkermansia mucinphila and Reduced Non-Esterified Fatty Acids and Energy Metabolism in HFD-Induced Obese Rats
  4. A multi-strain probiotic blend reshaped obesity-related gut dysbiosis and improved lipid metabolism in obese children
Previous Back to list Next
Back
TOP